Related Experiment Video
Updated: Apr 26, 2026
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
RASSF1A suppresses proliferation of cervical cancer cells
Lei Feng1, Jie Li, Ling-Di Yan
1Department of Gynecology and Obstetrics, People's Hospital of Pingyi County; Shandong Province, Pingyi, PR China
Background:
This study aimed to explore the effects of ras association domain family 1 A (RASSF1A) on proliferation and apoptosis of human cervical cancer cell line Hela cells.
Materials And Methods:
RASSF1A was cloned into the pcDNA3.1(+) vector to generate pcDNA3.1(+)-RASSF1A plasmid for transfection into Hela cells. Changes in the proliferation and apoptosis of cultured Hela cells were examined by the 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium chloride assay and flow cytometry. A protein array was used to analyze the expression of apoptotic factors.
Results:
Plasmid pcDNA3.1(+)-RASSF1A was generated and transfected into Hela cells to stably express RASSF1A in Hela cells. RASSF1A transfection was effective in inhibiting the proliferation of Hela cells up to 52.4%, as compared to cells transfected with an empty plasmid. RASSF1A expression also successfully induced apoptosis in human cervical cells with an apoptosis rate of 20.5%. More importantly, protein array results showed that RASSF1 A transfection induced overexpression of p21 and caspase 8, while decreasing the expression of survivin in Hela cells.
Conclusions:
RASSF1A expression was effective in suppressing the proliferation and increasing apoptosis of Hela cells, and may be a potential therapy for cervical cancer in clinic.
Insights
Ras association domain family 1 A (RASSF1A) inhibits human cervical cancer Hela cell proliferation and induces apoptosis. This suggests RASSF1A may be a potential therapeutic agent for cervical cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Investigates the role of Ras association domain family 1 A (RASSF1A) in cellular processes.
- Focuses on human cervical cancer cell line Hela cells.
Purpose of the Study:
- To explore the effects of RASSF1A on the proliferation and apoptosis of Hela cells.
- To determine the potential of RASSF1A as a therapeutic target for cervical cancer.
Main Methods:
- Cloning RASSF1A into pcDNA3.1(+) vector for transfection into Hela cells.
- Utilizing MTT assay and flow cytometry to assess proliferation and apoptosis.
- Employing protein array to analyze apoptotic factor expression.
Main Results:
- Successful stable expression of RASSF1A in Hela cells.
- RASSF1A inhibited Hela cell proliferation by 52.4% and induced apoptosis with a 20.5% rate.
- RASSF1A overexpression upregulated p21 and caspase 8, while downregulating survivin.
Conclusions:
- RASSF1A effectively suppresses proliferation and enhances apoptosis in Hela cells.
- RASSF1A demonstrates potential as a therapeutic strategy for cervical cancer.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
02:38The Ras Gene
Ras is a...
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity: